Clinical Trials · NCT05199714

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

Phase
N/A
Recruitment status
Completed
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment
12
Start date
Feb 2022
Locations
1 site, Canada
Primary endpoint
Each participant's percentage of time glucose levels spent in the target range
View Pramlintide compound reference